These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 21402845)
1. PME-1, an extended-spectrum β-lactamase identified in Pseudomonas aeruginosa. Tian GB; Adams-Haduch JM; Bogdanovich T; Wang HN; Doi Y Antimicrob Agents Chemother; 2011 Jun; 55(6):2710-3. PubMed ID: 21402845 [TBL] [Abstract][Full Text] [Related]
2. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Poirel L; Naas T; Nicolas D; Collet L; Bellais S; Cavallo JD; Nordmann P Antimicrob Agents Chemother; 2000 Apr; 44(4):891-7. PubMed ID: 10722487 [TBL] [Abstract][Full Text] [Related]
3. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Philippon LN; Naas T; Bouthors AT; Barakett V; Nordmann P Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046 [TBL] [Abstract][Full Text] [Related]
4. Acquisition of Extended-Spectrum β-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Poirel L; Ortiz De La Rosa JM; Kieffer N; Dubois V; Jayol A; Nordmann P Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323045 [TBL] [Abstract][Full Text] [Related]
5. OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain. Danel F; Hall LM; Gur D; Livermore DM Antimicrob Agents Chemother; 1997 Apr; 41(4):785-90. PubMed ID: 9087490 [TBL] [Abstract][Full Text] [Related]
6. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli. Silva J; Aguilar C; Ayala G; Estrada MA; Garza-Ramos U; Lara-Lemus R; Ledezma L Antimicrob Agents Chemother; 2000 Apr; 44(4):997-1003. PubMed ID: 10722503 [TBL] [Abstract][Full Text] [Related]
7. Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals. Celenza G; Pellegrini C; Caccamo M; Segatore B; Amicosante G; Perilli M J Antimicrob Chemother; 2006 May; 57(5):975-8. PubMed ID: 16510850 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains]. Zarakolu P; Metan G; Hasçelik G; Akova M Mikrobiyol Bul; 2005 Jul; 39(3):265-72. PubMed ID: 16358485 [TBL] [Abstract][Full Text] [Related]
10. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates]. Er H; Altındiş M; Aşık G; Demir C Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816 [TBL] [Abstract][Full Text] [Related]
11. OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates. Danel F; Hall LM; Gur D; Livermore DM Antimicrob Agents Chemother; 1998 Dec; 42(12):3117-22. PubMed ID: 9835501 [TBL] [Abstract][Full Text] [Related]
12. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015. Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073 [TBL] [Abstract][Full Text] [Related]
13. Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone. Arca-Suárez J; Fraile-Ribot P; Vázquez-Ucha JC; Cabot G; Martínez-Guitián M; Lence E; González-Bello C; Beceiro A; Rodríguez-Iglesias M; Galán-Sánchez F; Bou G; Oliver A Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383659 [TBL] [Abstract][Full Text] [Related]
14. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan. Ullah W; Qasim M; Rahman H; Khan S; Rehman ZU; Ali N; Muhammad N Microb Pathog; 2017 Apr; 105():240-244. PubMed ID: 28258003 [TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802. Rejiba S; Limam F; Belhadj C; Belhadj O; Ben-Mahrez K Microb Drug Resist; 2002; 8(1):9-13. PubMed ID: 12002654 [TBL] [Abstract][Full Text] [Related]
16. FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Pollini S; Maradei S; Pecile P; Olivo G; Luzzaro F; Docquier JD; Rossolini GM Antimicrob Agents Chemother; 2013 Jan; 57(1):410-6. PubMed ID: 23114762 [TBL] [Abstract][Full Text] [Related]
17. Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain. Juan C; Mulet X; Zamorano L; Albertí S; Pérez JL; Oliver A Antimicrob Agents Chemother; 2009 Dec; 53(12):5288-90. PubMed ID: 19770278 [TBL] [Abstract][Full Text] [Related]
18. BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa. Poirel L; Brinas L; Verlinde A; Ide L; Nordmann P Antimicrob Agents Chemother; 2005 Sep; 49(9):3743-8. PubMed ID: 16127048 [TBL] [Abstract][Full Text] [Related]
19. Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Pasteran F; Faccone D; Petroni A; Rapoport M; Galas M; Vázquez M; Procopio A Antimicrob Agents Chemother; 2005 Jan; 49(1):474-5. PubMed ID: 15616342 [No Abstract] [Full Text] [Related]
20. Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain. Juan C; Beceiro A; Gutiérrez O; Albertí S; Garau M; Pérez JL; Bou G; Oliver A Antimicrob Agents Chemother; 2008 Oct; 52(10):3589-96. PubMed ID: 18644957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]